Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 12, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 18
- 0 vs. Q4 2025
- Portfolio value
- $238.8M
- +$2.31M (+1.0%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SENSSenseonics Holdings, Inc. | COM | 2,171 | $14.2K | <0.1% | 00.0% | Unchanged | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $17.4K | <0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM NEW | 31,305 | $137.1K | 0.1% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 101,618 | $736.7K | 0.3% | −176,159−63.4% | Reduced | History |
| AGMBAgomAb Therapeutics NV | SPONSORED ADS | 75,000 | $813.8K | 0.3% | +75,000 | New | History |
| NXTCNextCure, Inc. | COM NEW | 153,354 | $1.54M | 0.6% | −4,292−2.7% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $2.00M | 0.8% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $3.74M | 1.6% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $4.23M | 1.8% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $5.50M | 2.3% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $8.35M | 3.5% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $9.21M | 3.9% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $11.9M | 5.0% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,838,913 | $16.8M | 7.1% | −131,109−4.4% | Reduced | History |
| CELCCelcuity Inc. | COM | 295,652 | $31.3M | 13.1% | −53,754−15.4% | Reduced | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $34.9M | 14.6% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $49.8M | 20.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,780,401 | $57.7M | 24.1% | −595,943−11.1% | Reduced | History |
Sold out since Q4 2025 (1)
Positions held at the end of Q4 2025 that are gone from this filing.